Kent Grindstaff
Doer · DISC type dsKent is a seasoned life sciences R&D executive and current Consulting Director at BioIVT, with extensive experience in drug discovery, preclinical development, and operations. He holds a Ph. D. from Washington University in St. Louis and is recognized by colleagues for his insightful, hands-on, and science-driven perspective in advancing therapeutic programs from concept to IND-enabling status.
Based in Boise, Idaho, Kent is a key opinion leader in the application of New Approach Methodologies (NAMs) to replace, reduce, and refine animal use in drug development. He frequently speaks at industry events and contributes to publications on the topic, advocating for a coordinated approach to validate and standardize human-relevant alternatives.
He has an h-index of 15 and has been cited over 3, 400 times for his scientific publications.
Read the full overview →How Kent shows up
Reading between the lines and seeing beyond your words comes naturally to them. They are very professional in their approach and can weigh multiple perspectives together. They might take some time to make their mind up but once they do, they don't change it easily.
Topics Kent cares about
Work history
Media appearances
DISC profile (public)
Dominance (D)
Dominance (D) reflects how goal and task oriented a person is, and their ability to accomplish results irrespective of how demanding the circumstances might be. Those scoring high tend to be motivated by winning, competition, and success.
Other BioIVT Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.